Guiqiang Zhang

701 total citations
41 papers, 568 citations indexed

About

Guiqiang Zhang is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Guiqiang Zhang has authored 41 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Biomedical Engineering and 12 papers in Immunology. Recurrent topics in Guiqiang Zhang's work include Nanoplatforms for cancer theranostics (18 papers), RNA Interference and Gene Delivery (12 papers) and Immunotherapy and Immune Responses (10 papers). Guiqiang Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), RNA Interference and Gene Delivery (12 papers) and Immunotherapy and Immune Responses (10 papers). Guiqiang Zhang collaborates with scholars based in China, United Kingdom and Poland. Guiqiang Zhang's co-authors include Jiwei Cui, Haifeng Sun, Xu Zhou, Shuxia Lu, Xizhao Wang, Xiao Fu, Jingcheng Hao, Shumei Zhai, Hongtao Liu and Yuguang Du and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemistry of Materials and Chemical Communications.

In The Last Decade

Guiqiang Zhang

38 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiqiang Zhang China 14 188 176 120 85 68 41 568
Wenwen Xu China 17 282 1.5× 256 1.5× 97 0.8× 78 0.9× 93 1.4× 36 905
Somayeh Sadeghi Iran 17 379 2.0× 100 0.6× 62 0.5× 79 0.9× 35 0.5× 48 1.2k
Lizhuo Zhang China 11 290 1.5× 218 1.2× 183 1.5× 45 0.5× 20 0.3× 37 706
Jiahao Wang China 16 336 1.8× 151 0.9× 39 0.3× 30 0.4× 82 1.2× 117 870
Yalda Yazdani Iran 12 196 1.0× 74 0.4× 34 0.3× 59 0.7× 63 0.9× 28 585
Xinyi Zhang China 16 660 3.5× 136 0.8× 167 1.4× 52 0.6× 27 0.4× 54 1.2k
Hongyu Zhou China 6 148 0.8× 113 0.6× 45 0.4× 67 0.8× 15 0.2× 18 505
Ye Xu China 13 156 0.8× 186 1.1× 37 0.3× 132 1.6× 78 1.1× 47 1.0k
Ji‐Seon Lee South Korea 15 250 1.3× 105 0.6× 31 0.3× 28 0.3× 89 1.3× 37 595

Countries citing papers authored by Guiqiang Zhang

Since Specialization
Citations

This map shows the geographic impact of Guiqiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiqiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiqiang Zhang more than expected).

Fields of papers citing papers by Guiqiang Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiqiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiqiang Zhang. The network helps show where Guiqiang Zhang may publish in the future.

Co-authorship network of co-authors of Guiqiang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Guiqiang Zhang. A scholar is included among the top collaborators of Guiqiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiqiang Zhang. Guiqiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yu‐Guo, et al.. (2025). Microplastics in aquatic environments: detection, abundance, characteristics, and toxicological studies. Environmental Monitoring and Assessment. 197(2). 150–150. 2 indexed citations
2.
Zhao, Yi‐Lei, Jie Yan, Wen Zhao, et al.. (2025). Dual metabolism-disrupted nanoparticles for reprogramming the immune microenvironment to potentiate cuproptosis immunotherapy. Materials Today Bio. 32. 101799–101799.
3.
Du, Jintao, et al.. (2025). Metabolic nanoblockers for synergistic cancer treatment through glutaminase inhibition and sonodynamic therapy. Ultrasonics Sonochemistry. 123. 107680–107680.
4.
Zhao, Yi‐Lei, Guoxin Zhu, Jie Yan, et al.. (2025). In situ carrier-free nanovaccines reversing the immunosuppressive microenvironment for boosting tumor immunotherapy. Chinese Chemical Letters. 37(2). 111031–111031. 1 indexed citations
5.
Yan, Jie, Yi‐Lei Zhao, Xiuying Duan, et al.. (2025). Targeted Degradation of EGFR Mutations via Self-Delivery Nano-PROTACs for Boosting Tumor Synergistic Immunotherapy. ACS Applied Materials & Interfaces. 17(14). 20943–20956. 6 indexed citations
7.
Liu, Wei, et al.. (2024). The two autophagy-related proteins 8a and 8b play distinct physiological roles in Drosophila. Genomics. 116(3). 110853–110853. 4 indexed citations
8.
Yan, Jie, Haijun Zhu, Yi‐Lei Zhao, et al.. (2024). Self-delivered sonodynamic nanomedicine for enhanced tumor immunotherapy by simultaneously reversing the immunosuppression and immune resistance. Chemical Engineering Journal. 501. 157580–157580. 1 indexed citations
9.
Zhao, Yi‐Lei, Xiaonan Zhao, Jie Yan, et al.. (2024). Polyphenol-mediated assembly of toll-like receptor 7/8 agonist nanoparticles for effective tumor immunotherapy. Acta Biomaterialia. 193. 417–428. 5 indexed citations
10.
Zhao, Yi‐Lei, Jie Yan, Xiaonan Zhao, et al.. (2024). Self-Assembled R848/Chlorin e6 Nanoparticles for Combinatorial Immunotherapy of Head and Neck Squamous Cell Carcinoma. ACS Applied Nano Materials. 7(7). 7966–7977. 4 indexed citations
11.
Zhang, Guiqiang, Ning Wang, Yuan Ma, et al.. (2024). Metal coordination‐driven assembly of stimulator of interferon genes‐activating nanoparticles for tumor chemo‐immunotherapy. SHILAP Revista de lepidopterología. 2(2). 23 indexed citations
12.
Zhao, Yi‐Lei, et al.. (2023). Hollow metal–organic framework-based, stimulator of interferon genes pathway-activating nanovaccines for tumor immunotherapy. Nanoscale Advances. 6(1). 72–78. 4 indexed citations
13.
Wang, Ning, Guiqiang Zhang, Peiyu Zhang, et al.. (2023). Vaccination of TLR7/8 Agonist‐Conjugated Antigen Nanoparticles for Cancer Immunotherapy. Advanced Healthcare Materials. 12(22). e2300249–e2300249. 20 indexed citations
14.
Zhang, Guiqiang, et al.. (2019). Robust fusion steady‐state filtering for multisensor networked systems with one‐step random delay, missing measurements, and uncertain‐variance multiplicative and additive white noises. International Journal of Robust and Nonlinear Control. 29(14). 4716–4754. 18 indexed citations
15.
Zhang, Guiqiang, Jing Liu, Ruilian Li, et al.. (2018). Conjugation of Inulin Improves Anti-Biofilm Activity of Chitosan. Marine Drugs. 16(5). 151–151. 18 indexed citations
16.
Wang, Yan, Yuxuan Wang, Sihong Liu, et al.. (2018). Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence. Biomedicine & Pharmacotherapy. 107. 606–614. 10 indexed citations
17.
Zhang, Guiqiang, et al.. (2018). Conjugation of chitosan oligosaccharides via a carrier protein markedly improves immunogenicity of porcine circovirus vaccine. Glycoconjugate Journal. 35(5). 451–459. 4 indexed citations
18.
Liu, Sihong, Jianwei Zhu, Yan Wang, et al.. (2016). Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 161. 77–82. 6 indexed citations
19.
Zhu, Jianwei, Ya Yang, Sihong Liu, et al.. (2016). Anticancer effect of thalidomide in vitro on human osteosarcoma cells. Oncology Reports. 36(6). 3545–3551. 12 indexed citations
20.
He, Yongsheng, et al.. (2016). Comparison of Stochastic Pre-Ignition Behaviors on a Turbocharged Gasoline Engine with Various Fuels and Lubricants. SAE technical papers on CD-ROM/SAE technical paper series. 1. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026